← Open Payments lookup

LAUREN TILLMAN: Open Payments

NPI 1629576368 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,172 in 110 payments from 17 companies in 2025. Trend: 2023 $1,789 · 2024 $1,440 · 2025 $2,172

Food & beverage: $2,172
CompanyPaymentsAmount
ABBVIE INC.29$509
Janssen Biotech, Inc.14$326
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$257
Gilead Sciences, Inc.8$159
NeurAxis, Inc.1$144
Takeda Pharmaceuticals U.S.A., Inc.6$116
Lilly USA, LLC6$113
Madrigal Pharmaceuticals4$94
Regeneron Healthcare Solutions, Inc.4$91
Ardelyx, Inc.5$83

Products named: TREMFYA, XIFAXAN, RINVOQ, CREON, DUPIXENT, OMVOH, LINZESS, REZDIFFRA.

Industry payments across IN — which companies pay providers there.